Navigation Links
Study finds parents use cough medicines on under-2s despite the warnings
Date:5/15/2008

More than 40 per cent of parents have used cough medicine for children younger than two even though it is not recommended, nor proven effective for children in this age group, an Australia-first study has found.

The joint University of Melbourne and Royal Childrens Hospital study, surveyed 325 parents at hospital outpatient clinics, maternal child health centres and child care centres about their use of over-the-counter medication for children aged 0-24 months.

It is the first study in Australia examining the use of over-the-counter medications among parents of children in this age group.

University of Melbourne Nursing PhD researcher Misel (pronounced Michelle) Trajanovska will present data from her study at the National Medicines Symposium 2008 in Canberra tomorrow (Friday 16 May).

She found:

  • 98 per cent had purchased an over-the-counter medication in the past year;

  • Paracetamol was the most commonly used drug (95.9 per cent);

  • 47.3 per cent had given their children topical teething gels;

  • Almost half (42.8 per cent) had given their children cough and cold medicines containing anti-histamines;

  • Nearly all parents had used over the counter medications to combat pain and fever;

  • About seven per cent of parents had given their child over-the-counter medication to induce sleep or settle their child;

  • Two parents had given their children paracetamol because they were cranky.

Ms Trajanovska said the use of cough and cold medicines on children under two was of particular concern.

Internationally there have been a number of reports of serious side effects among infants and children given over-the-counter cough medicines, she said.

There is also a lack of evidence that these medicines are even effective for treating coughs.

The Therapeutic Goods Administration recommends that these medicines should not be us
'/>"/>

Contact: Janine Sim-Jones
janinesj@unimelb.edu.au
040-089-3378
University of Melbourne
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
2. Study Supports Popular HIV Drug Regimen
3. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
4. Study shows that prostate cancer increases the risk of bone fracture
5. Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer
6. Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds
7. New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
8. Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors
9. Depression and anger can plague recent university graduates: Study
10. Rising Medical Solutions and CEO Are Featured as a Case Study in the Effective Small Business Management, Ninth Edition Textbook
11. Mayo Clinic study shows acupuncture and myofascial trigger therapy treat same pain areas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Tampa law firm prevails in countercla...against ConArt as part of business dispute over wo... Tampa, Fla. (Lexis Nexis) December... Keenan, P.A. recently completed the settlement o...,000 award for the firm,s client, ConArt, Inc., , ...
(Date:12/2/2009)...SAN DIEGO, Dec. 2 Gen-Pr...the 21st Annual Piper Jaffray Health Care Conferen...on is scheduled to be webcast live and may be acce...n-Probe,s website at www.gen-probe.com . The webc...ent. ,, About Gen-Probe ,, Gen-Probe Inco...
(Date:12/2/2009)... , SEATTLE, Dec. 2 Ce... announced today that Ruth Pettengell, M.D. of St.... investigator for the PIX 301 EXTEND trial will pr...n relapsed/refractory aggressive non-Hodgkin,s lym...ican Society of Hematology on Saturday, December 5...
(Date:12/1/2009)... Advocate Christ Medical Center in Oak...dney transplant center and the first for Chicago&r...al approval of the hospital’s plans today (D...ervices Review Board. , S...al Center in Oak Lawn, Ill. has become the state&...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Peptic Ulcer..., http://www.reportlinker.com/p0164350/Peptic-Ul...tml ,, The prevalence of peptic ulcers in de...than in developed countries. The bacteria, helicob...
Breaking Medicine News(10 mins):Health News:Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 2Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 3
...of pepsin, a digestive enzyme that is a marker for...ection of a lung transplant , according to resear...es further evidence that lung rejection may be cau...ng of stomach fluids into the lung] may contribute...
...ls are considering an overhaul in the process used...stic production . Last fall, grocers and sh...li-related illness linked to contaminated bagged s...finitively determine how the E. coli contaminated ...
...t giant Sony has apologised to the Church of Engla...a violent video game, a spokesman for the church ... to officials at Manchester Cathedral in north-wes... "If we have done so, we sincerely apologise," the...
...tralians taking to the bottle is not funny. Infact...eck in the health system, overburdened// by the fa...s health. Binge drinking has become a trend...ears. Many Australians will be suffering chronic d...
... old man that visits a doc, there is a woman; much... a woman, being the inspiration// for success. ...r, that too by a woman, a new survey has revealed ...er being coaxed and cajoled into seeing one. ...
... Prime Minister Surayud Chulanont, has defended hi...eneric versions of three patented// drugs-in spite...n the kingdom. "We still defend what we have d... Songkhla will be traveling to the United along wi...
Other Medicine News:Health News:Rejection in Lung Transplants Due to Elevated Pepsin Level 2Health News:FDAs Failure Urges It to Reassess Its Policies 2Health News:Thailand Unfazed As US Worries Over Copyright Violations 2
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Insulin Pumps (External) - A Worl...m/p0164247/Insulin-Pumps-External---A-World-Market...tinuous Subcutaneous Insulin Infusion (CSII), prov... other forms of treatment. Insulin pump is a pager...
(Date:12/1/2009)... 1 Johnson & Johnson Pharmaceu... today that it has submitted a New Drug Applicatio...FDA) for tapentadol extended release (ER) tablets,...ent of moderate to severe chronic pain in patients...fined as pain that persists for long periods of ti...
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Latin American Pharmaceutical Ma...nalysis, forecasts and growth opportunities ,...rican-Pharmaceutical-Market-Outlook-To-2014-Policy...opportunities.html ,, The $28.8bn Latin Amer...
Breaking Medicine Technology:Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8Patient Advocate Foundation Announces Additional Support for Co Pay Relief Program Serving Multiple Myeloma Patients 61220 1Patient Advocate Foundation Announces Additional Support for Co Pay Relief Program Serving Multiple Myeloma Patients 61220 2Amgen to Present at 18th Annual Credit Suisse Healthcare Conference 61216 1Amgen to Present at 18th Annual Credit Suisse Healthcare Conference 61216 2Champions Biotechnology to Present Data at AACR EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft 28TM 29 Platform to Guide Personalized C 14808 1Champions Biotechnology to Present Data at AACR EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft 28TM 29 Platform to Guide Personalized C 14808 2Champions Biotechnology to Present Data at AACR EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft 28TM 29 Platform to Guide Personalized C 14808 3Champions Biotechnology to Present Data at AACR EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft 28TM 29 Platform to Guide Personalized C 14808 4
...ill seem radically innovative in the context of ma...the manufacturing sector had been the norm for man...mated lines fabricate sub-assemblies and entire ve...esult has been vastly improved products, far fewer...it and productivity. These days, only a handful of...
...e recent proliferation of rapid, easy-to-use diagn...ave entered the marketplace to help clinicians ass...d to screen for the presence of drugs of abuse. So...ile many simple test kits are suitable for point o...nd workplace use. , , Therapeutic drug monitor...
Other Medicine Technology:Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
Distal Femoral Nail
NeuroMax1004
...eld potential vision tester measures retinal acuit.... Potential vision testing requires two related t...nown as the Illuminated Near Card) and the RAM Pin...s). The fastest, easiest, and most accurate poten...
ACCU-Beam® Video + Digital SLR Camera Adaptor
Medicine Products: